A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.
People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.
Primary Sponsor
Trans Tasman Radiation Oncology Group (TROG)
Collaborating Groups
NCI CTG (ES 2)
Final Accrual
220
Trial Chairperson
Dr Michael Penniment, Royal Adelaide Hospital, SA
Trial Contact
sonya.stephens@health.sa.gov.au
Clinical Trial Registration
Related Post
October 18, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
September 6, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
